For Black Americans, the battle with Chronic Myeloid Leukemia is marked by unique survival challenges and treatment ...

The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a ...

Ibrutinib remains a key treatment for relapsed chronic lymphocytic leukemia (CLL), but findings suggest that combining it ...

Edward Ratner has lived with chronic lymphocytic leukemia for a decade. Here, the Minneapolis doctor shares his rules for success.

Immunotherapy research primarily focuses on improving the body’s immune system’s recognition of cancer cells. However, ...

Researchers sought to determine whether zanubrutinib is more beneficial than ibrutinib in patients with CLL/SLL.

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune ...

Eli Lilly said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its Jaypirca cancer drug in certain patients with chronic lymphocytic ...